Nasonex Delivery Failures Are Among Observations In Schering FDA-483s
Executive Summary
One theme of FDA's recent inspections of Schering-Plough's Manati, Puerto Rico manufacturing facility is the reliability of the nasal spray delivery system for Nasonex (mometasone).
You may also be interested in...
Schering GMP Criminal Investigation Continues After Consent Decree
Schering-Plough faces a potential criminal case regarding GMP violations after finalizing a consent agreement with FDA May 17
Schering Albuterol Recall Linked With 24 Fatalities, Public Citizen Asserts
Schering-Plough's testing of albuterol inhalers returned to the company shows that in every case where an injury is alleged to have occurred because of a faulty inhaler, the canister contained active ingredient, the company maintains.
Schering Albuterol Recall Linked With 24 Fatalities, Public Citizen Asserts
Schering-Plough's testing of albuterol inhalers returned to the company shows that in every case where an injury is alleged to have occurred because of a faulty inhaler, the canister contained active ingredient, the company maintains.